Relationship and prognostic value of modified coronary artery calcium score, FEV1, and emphysema in lung cancer screening population: the MILD trial.

PURPOSE To assess the relationship between a modified coronary artery calcium (mCAC) score and both forced expiratory volume in 1 second (FEV1) and pulmonary emphysema and the associations of such factors with all-cause mortality and cardiovascular events (CVEs) in a lung cancer computed tomographic (CT) screening trial. MATERIALS AND METHODS In this institutional review board-approved study, both clinical and low-dose CT data were evaluated in a cohort of heavy smokers consecutively recruited by the Multicentric Italian Lung Detection, or MILD, trial. Low-dose CT images were analyzed by using software that allowed quantification of mCAC, mean lung attenuation (MLA), and total extent of emphysema. The correlations between mCAC, percentage predicted FEV1, MLA, and emphysema extent were tested by using the Pearson correlation coefficient. Adjusted multiple logistic regression models were applied to assess the relationships between mCAC, FEV1, MLA, and emphysema extent and all-cause mortality and CVEs. RESULTS The final study cohort consisted of 1159 smokers. There were no significant correlations between mCAC score and FEV1 (r=-0.03, P=.4), MLA (r=-0.01, P=.7), or emphysema extent (r=0.02, P=.6). An mCAC score greater than 400 was the only factor that was independently associated with both all-cause mortality (odds ratio [OR]: 3.73; 95% confidence interval [CI]: 1.05, 13.32; P=.04) and CVEs (OR: 2.87; 95% CI: 1.13, 7.27; P=.03). CONCLUSION mCAC is a better predictor of CVE and all-cause mortality than FEV1 and emphysema extent and may contribute to the identification of high-risk individuals in a lung cancer screening setting.

[1]  R. Detrano,et al.  Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. , 2004, JAMA.

[2]  Don D. Sin,et al.  Why Are Patients With Chronic Obstructive Pulmonary Disease at Increased Risk of Cardiovascular Diseases?: The Potential Role of Systemic Inflammation in Chronic Obstructive Pulmonary Disease , 2003 .

[3]  D. Sin,et al.  The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. , 2005, Chest.

[4]  David F Yankelevitz,et al.  Frequency of coronary artery calcification on low-dose computed tomography screening for lung cancer. , 2006, Clinical imaging.

[5]  P. Burney,et al.  References values for forced spirometry. Group of the European Community Respiratory Health Survey. , 1998, The European respiratory journal.

[6]  R. Detrano,et al.  Quantification of coronary artery calcium using ultrafast computed tomography. , 1990, Journal of the American College of Cardiology.

[7]  D. Rader,et al.  Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons. , 1999, Mayo Clinic proceedings.

[8]  A. Ionescu,et al.  Inflammatory response and body composition in chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[9]  Tapio Vehmas,et al.  Relación entre las calcificaciones ateroscleróticas en el tórax detectadas mediante tomografía computarizada y la función pulmonar , 2009 .

[10]  E. Russi,et al.  Coronary artery disease in patients undergoing lung volume reduction surgery for emphysema. , 1997, Chest.

[11]  Ming-Ting Wu,et al.  Coronary arterial calcification on low-dose ungated MDCT for lung cancer screening: concordance study with dedicated cardiac CT. , 2008, AJR. American journal of roentgenology.

[12]  S. Bergmann,et al.  Coronary artery calcification and emphysema. , 2008, The Canadian journal of cardiology.

[13]  Ugo Pastorino,et al.  Pulmonary nodules: volume repeatability at multidetector CT lung cancer screening. , 2009, Radiology.

[14]  P De Vuyst,et al.  Comparison of computed density and macroscopic morphometry in pulmonary emphysema. , 1995, American journal of respiratory and critical care medicine.

[15]  Josep Roca,et al.  References values for forced spirometry , 1998 .

[16]  Matthew J Budoff,et al.  Expert review on coronary calcium , 2008, Vascular health and risk management.

[17]  J. Erikssen,et al.  Lung function, smoking and mortality in a 26-year follow-up of healthy middle-aged males , 2005, European Respiratory Journal.

[18]  H. Peitgen,et al.  Informatics in radiology (infoRAD): new tools for computer assistance in thoracic CT. Part 1. Functional analysis of lungs, lung lobes, and bronchopulmonary segments. , 2005, Radiographics : a review publication of the Radiological Society of North America, Inc.

[19]  B. Make,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[20]  D. Berman,et al.  Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. , 2003, Radiology.

[21]  Yasutaka Nakano,et al.  CT scan findings of emphysema predict mortality in COPD. , 2010, Chest.

[22]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[23]  David G. Anderson,et al.  Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.

[24]  L. Kuller,et al.  Coronary Artery Calcification in Older Adults to Age 99: Prevalence and Risk Factors , 2001, Circulation.

[25]  C. Begg,et al.  Computed Tomography Screening and Lung Cancer Outcomes , 2008 .

[26]  Rowena Yip,et al.  Ordinal scoring of coronary artery calcifications on low-dose CT scans of the chest is predictive of death from cardiovascular disease. , 2010, Radiology.

[27]  E. Topol,et al.  Prevalence of Conventional Risk Factors in Patients With Coronary Heart Disease , 2003 .

[28]  Harry J de Koning,et al.  Comparing coronary artery calcium and thoracic aorta calcium for prediction of all-cause mortality and cardiovascular events on low-dose non-gated computed tomography in a high-risk population of heavy smokers. , 2010, Atherosclerosis.

[29]  C. la Vecchia,et al.  Interstitial lung diseases in a lung cancer screening trial , 2011, European Respiratory Journal.

[30]  P. Piirilä,et al.  Relation between atherosclerotic calcifications detected in chest computed tomography and lung function , 2009 .